New York, NY -- (SBWIRE) -- 12/10/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Amarin Corporation plc (ADR) (NASDAQ:AMRN), Sodastream International Ltd (NASDAQ:SODA), Barrick Gold Corporation (USA) (NYSE:ABX), TITAN MEDICAL INC (OTCMKTS:TITXF)
Amarin Corporation plc (ADR) (NASDAQ:AMRN) showed a volume of 2.17 million shares by the end of last trade whereas the average volume of the stock remained 6.30 million shares. The stock opened the session at $1.80 but then moved to $1.73. At that price, the stock showed a negative performance of -2.26%. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels, or hypertriglyceridemia. In September 2011,
Will AMRN Get Buyers Even After The Recent Rally? Find Out Here
Sodastream International Ltd (NASDAQ:SODA) opened the session at $53.26 and closed the session at $55.76. The stock showed a positive performance of 4.56% in previous trading session. Traded with volume of 2.59 million shares in the prior session and the average volume of the stock remained 872,308.00 shares. SodaStream International Ltd., formerly Soda-Club Holdings Ltd., along with its subsidiaries, is engaged in developing, manufacturing and marketing home beverage carbonation systems and related products. The Company’s operational activities are managed by Soda-Club International BV (SCBV), wholly owned subsidiary of Soda-Club Enterprises N.V. (SCNV), whch is the wholly owned subsidiary of the Company. SodaStream manufactures home beverage carbonation systems, which enable consumers to transform ordinary tap water into carbonated soft drinks and sparkling water.
For How Long SODA will fight for Profitability? Read This Trend Analysis report
Barrick Gold Corporation (USA) (NYSE:ABX) opened the session at $15.63 and closed the session at $16.00. The stock showed a positive performance of 3.90% in previous trading session. Traded with volume of 17.70 million shares in the prior session and the average volume of the stock remained 20.48 million shares. The beta of the stock remained 0.45. Barrick Gold Corporation (Barrick) is engaged in the production and sale of gold, as well as related activities, such as exploration and mine development. Barrick also produces copper, principally from the Zaldivar and Lumwana mines and holds other interests, including a nickel development project located in Africa. Barrick’s business is organized into seven primary operating segments: four regional gold businesses, a global copper business unit, an oil and gas business, and a capital projects group. Its producing gold mines are concentrated in three regional business units (RBU): North America,
Why Should Investors Buy ABX After The Recent Gain? Just Go Here and Find Out
TITAN MEDICAL INC (OTCMKTS:TITXF) the stock decreased -10.03% and finished the session at $0.927. Traded with volume of 586,383.00 shares in the prior session and the average volume of the stock remained 270,921.00 shares.
Will TITXF Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)